DuPont

The San Francisco-based startup, which closed a $5 million Series A round in 2017, aims to develop nutritionally enhanced food and feed crops.

The collaborators will grant the licenses to any entities wanting to use the technology for commercial agricultural research and product development.

DuPont Pioneer has acquired the exclusive rights to ERS Genomics' portfolio of CRISPR-Cas genome-editing technologies for all plant and agricultural applications.

The company said its acquisition of DuPont Diagnostics will allow it to provide a broader array of food safety diagnostics services to its customers.

DuPont Pioneer has entered into a collaboration to apply CRISPR genome editing to the development of crop varieties for farmers in developing countries.

The firms also renewed distribution agreements for DuPont's BAX System Q7 food safety testing platform in Canada, Australia and New Zealand.

The in vitro assay enabled the scientists to take an uncharacterized Cas9 variant from Brevibacillus laterosporus and edit maize cells with it.